US Patent Issued to HYSENSBIO, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION on May 19 for "Compositions for diagnosis, prevention, or treatment of fatty liver disease" (South Korean Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,879, issued on May 19, was assigned to HYSENSBIO (Gwacheon-si, South Korea) and SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (Seoul, South Korea).

"Compositions for diagnosis, prevention, or treatment of fatty liver disease" was invented by Joo Cheol Park (Seoul, South Korea), Dong Seol Lee (Seoul, South Korea) and Geumbit Hwang (Ansan-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "CPNE7 protein or a nucleotide encoding for CPNE7 protein, or compositions containing the CPNE7 or the nucleotide and their uses are disclosed. The protein, nucleotide, or composition is useful for preventing or treating fatty liver disease. The CPEN7 protein r...